KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Receivables (2016 - 2025)

Historic Receivables for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $9.6 billion.

  • Amgen's Receivables rose 3104.2% to $9.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $9.6 billion, marking a year-over-year increase of 3104.2%. This contributed to the annual value of $9.6 billion for FY2025, which is 3104.2% up from last year.
  • According to the latest figures from Q4 2025, Amgen's Receivables is $9.6 billion, which was up 3104.2% from $8.5 billion recorded in Q3 2025.
  • Amgen's Receivables' 5-year high stood at $9.6 billion during Q4 2025, with a 5-year trough of $4.4 billion in Q1 2021.
  • Its 5-year average for Receivables is $6.5 billion, with a median of $6.2 billion in 2022.
  • Per our database at Business Quant, Amgen's Receivables plummeted by 1653.0% in 2021 and then surged by 3104.2% in 2025.
  • Quarter analysis of 5 years shows Amgen's Receivables stood at $5.7 billion in 2021, then grew by 10.36% to $6.3 billion in 2022, then rose by 24.06% to $7.8 billion in 2023, then dropped by 6.01% to $7.3 billion in 2024, then soared by 31.04% to $9.6 billion in 2025.
  • Its Receivables stands at $9.6 billion for Q4 2025, versus $8.5 billion for Q3 2025 and $8.7 billion for Q2 2025.